TickerFacts.

Atossa Therapeutics, Inc. (ATOS): Depreciation & Amortization

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2014-12-31, 2020-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest Depreciation & Amortization is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$8.0K
Year ended 2022-12-31
$480.3K2011-12-31: $15.6K2012-12-31: $130.6K2013-12-31: $472.9K2014-12-31: $480.3K2015-12-31: $272.6K2016-12-31: $303.5K2017-12-31: $129.0K2018-12-31: $44.2K2019-12-31: $52.8K2020-12-31: $47.0K2021-12-31: $23.0K2022-12-31: $8.0K$8.0K
2011-12-31 Depreciation & Amortization (USD) 2022-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2022-12-31$8.0K-65.2%2023-03-22, From 2022-01-01
2021-12-31$23.0K-51.1%2023-03-22, From 2021-01-01
2020-12-31$47.0Kn/c2022-02-28, From 2020-01-01
2019-12-31$52.8K+19.4%2021-03-31, From 2019-01-01
2018-12-31$44.2K-65.7%2020-03-26, From 2018-01-01
2017-12-31$129.0K-57.5%2019-03-28, From 2017-01-01
2016-12-31$303.5K+11.3%2018-03-08, From 2016-01-01
2015-12-31$272.6K-43.2%2017-03-21, From 2015-01-01
2014-12-31$480.3Kn/c2016-03-30, From 2014-01-01
2013-12-31$472.9K+262.3%2015-03-30, From 2013-01-01
2012-12-31$130.6K+735.6%2014-03-27, From 2012-01-01
2011-12-31$15.6Kn/a2013-03-28, From 2011-01-01